Saudi lymphoma group's clinical practice guidelines for diagnosis, management and follow-up of patients with various types of lymphoma during the Coronavirus Disease 2019 pandemic

Musa Alzahrani¹, Mubarak M Al-Mansour², John Apostolidis³, Ahmed Barefah⁴, Reyad Dada⁵, Ayman Alhejazi⁶, Yasir Alayed⁷, Ibraheem Motabi⁸, Mansoor Radwi⁹, Hani Al-Hashmi^3
1 Department of Medicine and Oncology Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia
² Department of Medicine, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah; Princess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs-Western Region, Dammam, Saudi Arabia
³ Department of Adult Hematology and Stem Cell Transplantation, Oncology Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia
⁴ Department of Hematology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
⁵ Department of Oncology, King Faisal Specialist Hospital and Research Centre, Jeddah; Department of Medicine, College of Medicine, Al-Faisal University, Riyadh, Saudi Arabia
⁶ Department of Oncology, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia
⁷ Radiation Oncology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
⁸ Department of Adult Hematology and BMT, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia
⁹ Department of Hematology, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia

Correspondence Address:
Dr. Musa Alzahrani
Department of Medicine, College of Medicine, King Khalid University Hospital, P.O. Box: 7805, Riyadh 11472 DEM 65
Saudi Arabia

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/sjmms.sjmms_457_20